Article December 1, 2003

Introduction. Ziprasidone in Schizophrenia: From Acute Treatment to Long-Term Management

John M. Kane, MD

J Clin Psychiatry 2003;64(suppl 19):3-5

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Schizophrenia is a highly complex, chronic, often lifelong, mental illness that severely compromises social, intellectual, and occupational functioning. About 1% ofthe population will develop schizophrenia, and annuallymore than 2 million Americans suffer from the disorder.1People with schizophrenia on average live 15 fewer yearsthan individuals in the general population, dying prematurely of natural (e.g., cardiovascular and respiratory diseases) as well as unnatural causes (primarily suicide).2‘ ‹